Ned Adams
About
In The Last Decade
Ned Adams
9 papers receiving 319 citations
Peers
Comparison fields: 5 of 50
- Molecular Biology 169
- Genetics 151
- Oncology 145
- Biotechnology 90
- Physiology 36
Countries citing papers authored by Ned Adams
This map shows the geographic impact of Ned Adams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ned Adams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ned Adams more than expected).
Fields of papers citing papers by Ned Adams
This network shows the impact of papers produced by Ned Adams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ned Adams. The network helps show where Ned Adams may publish in the future.
Co-authorship network of co-authors of Ned Adams
This figure shows the co-authorship network connecting the top 25 collaborators of Ned Adams. A scholar is included among the top collaborators of Ned Adams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ned Adams. Ned Adams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 6 | |
| 3 | 14 | |
| 4 | 5 | |
| 5 | 205 | |
| 6 | 5 | |
| 7 | Phase I trial of an all-oral combination chemotherapy regimen: topotecan and capecitabine in solid tumor patients. | 1 |
| 8 | 3 | |
| 9 | 63 | |
| 10 | 24 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.